DR. AMARTEJ MERLA MD NPI 1902097744

NPI Information

  • NPI: 1902097744
  • Provider Name: DR. AMARTEJ MERLA, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 44151 15TH ST W
    LANCASTER, CA
    ZIP 93534
  • Phone: (661) 902-5600

Map and Directions

Get Directions

NPI Details

DR. Amartej Merla, MD is a hematology and oncology internal medicine in Lancaster, CA with 24 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Amartej Merla, MD NPI is 1902097744. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

44151 15TH ST W
LANCASTER, CA
ZIP 93534-079
Phone: (661) 902-5600
Fax: (661) 951-0686

The NPI 1902097744 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Unclassified drugs (HCPCS:J3490)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Instillation of anti-cancer drug into bladder (HCPCS:51720)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)

The enumeration date for this NPI number is 8/7/2007 and was last updated on 5/18/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology143527CALIFORNIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.